# Perceptive Advisors: portfolio, investments and team

> Perceptive Advisors is an asset manager based in United States. 206 investments on record, 50 in the last 12 months, latest Oct 2026.

Source: https://millionrounds.com/fund/perceptive-advisors (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Perceptive Advisors

Last cheque observed Oct 2026; 206 cheques on record.

Email

Deploying now Asset manager

Seed Series A Series B Healthcare Biotech Life Sciences

Follow Perceptive Advisors and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fperceptive-advisors)

Deploying now

**81%** of best year **50** **cheques in 12 months**, 206 on record

Since the last cheque **18** days **00** hrs **00** min **00** sec

Median round **$100M** Cheque size, as they say **$100K – $10M** Rounds led **8 of 206** Sole investor **14 rounds** Exits **2 from the portfolio** Mostly in **United States, 93%**

Pitch Perceptive Advisors

## Perceptive Advisors highlights

- 01 50 cheques in the last 12 months
- 02 Mostly Series B and Series C: 48% of its rounds
- 03 Sole investor in 14 rounds, median $33M
- 04 2 exits from the portfolio

## What they do

> investing across the capital structure in both private and public companies to fuel innovation From their own website

- **Type:** Asset manager
- **Cheque size:** $100K – $10M as they say
- **Stages:** Seed Series A Series B Growth Pre-IPO
- **Sectors:** Healthcare Biotech Life Sciences
- **Based in:** New York, United States
- **Cold pitches:** Not accepted

## The record

Every round we can evidence, newest first **206 appearances**

- **2026** 41 rounds
- **Oct** **[Alaunos Therapeutics](https://millionrounds.com/company/alaunos-therapeutics)** US · Google News search **$350M** With 6 others
- **Sept** **[Pyxis Oncology](https://millionrounds.com/company/pyxis-oncology)** US **$110M** With 4 others
- **Sept** **[Beta Bionics](https://millionrounds.com/company/beta-bionics)** US **$173M** With 3 others
- **Sept** **[Twin Health](https://millionrounds.com/company/twin-health)** Venture · US **$59M** With 4 others
- **Aug** **[Vaderis Therapeutics](https://millionrounds.com/company/vaderis-therapeutics)** Series B · CH · Firms' own news pages **$152M** With 8 others
- **Jul** **[MeiraGTx](https://millionrounds.com/company/meiragtx)** Debt · US **$125M** With 2 others
- **Jul** **[Clearside Biomedical](https://millionrounds.com/company/clearside-biomedical)** Debt · US **$3.0M** With 2 others
- **Jul** **[DarioHealth](https://millionrounds.com/company/dariohealth)** US **$24M** With 2 others
- **Jul** **[BridgeBio](https://millionrounds.com/company/bridgebio)** US · Firms' own news pages **$1.0B** With 4 others
- **Jun** **[SonoThera](https://millionrounds.com/company/sonothera)** Series B · US · Ventureburn **$125M** *Led*
- **Jun** **[CereVasc](https://millionrounds.com/company/cerevasc)** Series C · US · Ventureburn **$85M** With 6 others
- **Jun** **[Scribe Therapeutics](https://millionrounds.com/company/scribe-therapeutics)** Grant · US **$25M** With 4 others
- **Jun** **[Neuron23](https://millionrounds.com/company/neuron23)** Grant · US **$2.5M** With 3 others
- **Jun** **[Absci](https://millionrounds.com/company/absci)** US **$100M** With 3 others
- **Jun** **[SOPHiA GENETICS](https://millionrounds.com/company/sophia-genetics)** US **$58M** With 4 others
- **Jun** **[Nuvation Bio](https://millionrounds.com/company/nuvation-bio)** Debt · US **$250M** With 4 others
- **Jun** **[IDEAYA Biosciences](https://millionrounds.com/company/ideaya-biosciences)** US **$345M** With 3 others
- **Jun** **[4D Molecular Therapeutics](https://millionrounds.com/company/4d-molecular-therapeutics)** Debt · US **$200M** With 3 others
- **May** **[Apogee Therapeutics](https://millionrounds.com/company/apogee-therapeutics)** Debt · US **$1.3B** With 3 others
- **May** **[Orchestra BioMed](https://millionrounds.com/company/orchestra-biomed)** Debt · US **$35M** With 1 other
- **May** **[Relay Therapeutics](https://millionrounds.com/company/relay-therapeutics)** US **$275M** With 3 others
- **Apr** **[MeiraGTx](https://millionrounds.com/company/meiragtx)** US **$100M** Sole investor
- **Apr** **[Opus Genetics](https://millionrounds.com/company/opus-genetics)** Debt · US **$35M** With 1 other
- **Apr** **[Allogene Therapeutics](https://millionrounds.com/company/allogene-therapeutics)** US **$200M** With 2 others
- **Apr** **[Forte Biosciences](https://millionrounds.com/company/forte-biosciences)** US **$150M** With 2 others
- **Apr** **[Spyre Therapeutics](https://millionrounds.com/company/spyre-therapeutics)** US **$403M** With 3 others
- **Apr** **[Oruka Therapeutics](https://millionrounds.com/company/oruka-therapeutics)** US **$700M** With 3 others
- **Apr** **[Outlook Therapeutics](https://millionrounds.com/company/outlook-therapeutics)** US **$5.0M** Sole investor
- **Mar** **[Imperative Care, Inc.](https://millionrounds.com/company/imperative-care-inc)** US · Elevage Medical Technologies **$100M** *Led*
- **Mar** **[Zenas BioPharma](https://millionrounds.com/company/zenas-biopharma)** US **$100M** With 4 others
- **Mar** **[Alto Neuroscience](https://millionrounds.com/company/alto-neuroscience)** US **$120M** With 4 others
- **Mar** **[Outlook Therapeutics](https://millionrounds.com/company/outlook-therapeutics)** Debt · US **$18M** Sole investor
- **Mar** **[Hyperfine](https://millionrounds.com/company/hyperfine)** Debt · US **$40M** With 1 other
- **Mar** **[Solid Biosciences](https://millionrounds.com/company/solid-biosciences)** US · Firms' own news pages **$240M** With 8 others
- **Mar** **[Inhibrx](https://millionrounds.com/company/inhibrx)** Debt · US **$75M** With 4 others
- **Mar** **[GenSight Biologics](https://millionrounds.com/company/gensight-biologics)** FR **$2.0M** With 4 others
- **Feb** **[Xilio Therapeutics](https://millionrounds.com/company/xilio-therapeutics)** US **$40M** With 3 others
- **Feb** **[COMPASS Pathways](https://millionrounds.com/company/compass-pathways)** GB **$200M** With 4 others
- **Feb** **[Beam Therapeutics](https://millionrounds.com/company/beam-therapeutics)** Debt · US **$100M** With 5 others
- **Feb** **[Talkiatry](https://millionrounds.com/company/talkiatry)** Series D · US **$210M** With 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **4 named**

AR **Alexander Rakitin** Chief Compliance Officer i Form ADV

JH **James Henry Mannix** Chief Operating Officer i Form ADV

JE **Joseph Eric Edelman** Chief Executive Officer and Portfolio Manager i Form ADV

PW **Peter William Fierro** Chief Financial Officer i Form ADV

We also hold **17** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$12B** assets it manages Oct 2026

**Registered** investment adviser full reporting to the SEC

- **Legal name:** Perceptive Advisors LLC.
- **SEC number:** CRD 154703

Funds on its Form ADV

**20** private funds, **$9.6B** in gross assets · filed Aug 2024

Private equity **9** Hedge **5** Credit-related fund **4**

- Perceptive Life Sciences Master Fund, LTD *Hedge* 400 investors $5.6B
- Perceptive Credit Opportunities Fund IV, L.P. *Hedge* 285 investors $1.4B
- Perceptive Credit Opportunities Fund III, L.P. *Hedge* 151 investors $1.1B
- Perceptive Credit Opportunities Fund II, L.P. *Hedge* 123 investors $540M
- Perceptive Xontogeny Venture Fund II, L.P. *Venture* 181 investors $508M
- PCOF Phoenix II Fund, L.P. *Hedge* 4 investors $207M
- Perceptive Xontogeny Venture Fund, L.P. *Venture* 134 investors $179M
- LEV LB Holdings, L.P. *Private equity* 37 investors $98M
- PCOF EQ AIV III, L.P. *Credit-related fund* 101 investors $7.0M
- Perceptive LS (A), LLC *Private equity* 5 investors $6.8M

And 10 more on the filing.

## Exits from the portfolio

Companies it backed that were later bought or listed **2 in all**

**[EUSA Pharma](https://millionrounds.com/company/eusa-pharma)** Bought by [Jazz Pharmaceuticals](https://millionrounds.com/fund/jazz-pharmaceuticals) **$650M** Apr 2012

**[EUSA Pharma](https://millionrounds.com/company/eusa-pharma)** Bought by EUSA Pharma **$23M** Mar 2008

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Seed Series A Series B

Median round joined **$100M** the round, not its cheque Alone, median **$33M**

Led 8 of 206 rounds **4%**

- **Said size:** $100K – $10M
- **Sole investor:** 14 rounds
- **Last cheque:** Oct 2026
- **Exits:** 2 from the portfolio

Rounds by stage said on their site

- Series B said *29*
- Series C *22*
- Debt *21*
- Series A said *18*
- Venture *17*
- Seed said *-*
- Growth said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) 45
- [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) 26
- [Redmile Group](https://millionrounds.com/fund/redmile-group) 25
- [Wellington Management](https://millionrounds.com/fund/wellington-management) 25
- [OrbiMed](https://millionrounds.com/fund/orbimed) 23
- [Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors) 22

**Pitching Perceptive Advisors?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Perceptive Advisors. A count of rooms they were both in, not a relationship either has claimed.

[**RA Capital Management** Private equity **45** rounds together](https://millionrounds.com/fund/ra-capital-management)[**Cormorant Asset Management** Private equity **26** rounds together](https://millionrounds.com/fund/cormorant-asset-management)[**Redmile Group** VC firm **25** rounds together](https://millionrounds.com/fund/redmile-group)[**Wellington Management** VC firm **25** rounds together](https://millionrounds.com/fund/wellington-management)[**OrbiMed** Private equity **23** rounds together](https://millionrounds.com/fund/orbimed)[**Janus Henderson Investors** Private equity **22** rounds together](https://millionrounds.com/fund/janus-henderson-investors)[**RTW Investments LLC** Growth equity **17** rounds together](https://millionrounds.com/fund/rtw-investments-lp)[**Fidelity** VC firm **15** rounds together](https://millionrounds.com/fund/fidelity)[**Foresite Capital** Private equity **12** rounds together](https://millionrounds.com/fund/forsite-capital)[**Vivo Capital** Private equity **12** rounds together](https://millionrounds.com/fund/vivo-capital)[**Adage Capital Management** Asset manager **11** rounds together](https://millionrounds.com/fund/adage-capital-management)[**Bain Capital Life Sciences** Private equity **10** rounds together](https://millionrounds.com/fund/bain-capital-life-sciences)

## Recently backed

The latest companies Perceptive Advisors put money into.

[**Pyxis Oncology** $110M · Sept 2026](https://millionrounds.com/company/pyxis-oncology)[**Beta Bionics** $173M · Sept 2026](https://millionrounds.com/company/beta-bionics)[**Twin Health** $59M · Sept 2026](https://millionrounds.com/company/twin-health)[**Clearside Biomedical** $3.0M · Jul 2026](https://millionrounds.com/company/clearside-biomedical)[**DarioHealth** $24M · Jul 2026](https://millionrounds.com/company/dariohealth)[**BridgeBio** $1.0B · Jul 2026](https://millionrounds.com/company/bridgebio)

## Quick answers about Perceptive Advisors

### What does Perceptive Advisors invest in?

Perceptive Advisors invests most often at Series B and Series C (48% of the rounds on record), in sectors such as Healthcare, Biotech and Life Sciences.

### How active is Perceptive Advisors?

206 investments on record, 50 of them in the last 12 months, and it led 8. The most recent was in Oct 2026.

### What has Perceptive Advisors invested in recently?

Its most recent investments on record: Alaunos Therapeutics (Undisclosed round, Oct 2026), Pyxis Oncology (Undisclosed round, Sept 2026) and Beta Bionics (Undisclosed round, Sept 2026).

### How big are Perceptive Advisors's cheques?

The median round it joins is $100M. It says it writes cheques of $100K to $10M.

### Does Perceptive Advisors lead rounds?

Sometimes: it led 8 of its 206 investments on record (4%).

### Where does Perceptive Advisors invest?

Most of the companies it backs are in the United States (93%).

### Is Perceptive Advisors investing now?

Yes: it is actively investing, with 50 investments in the last 12 months.

### Who does Perceptive Advisors invest alongside?

Most often RA Capital Management (45 rounds together), Cormorant Asset Management (26 rounds together) and Redmile Group (25 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=perceptive-advisors) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=perceptive-advisors)